Cita APA

Takayama, T., Shimizu, T., Abu Lila, A. S., Kanazawa, Y., Ando, H., Ishima, Y., & Ishida, T. (2020). Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil(®)) in C26 Tumor-Bearing Immunocompetent Mice. Pharmaceutics.

Chicago Style Citation

Takayama, Takuma, Taro Shimizu, Amr S. Abu Lila, Yuki Kanazawa, Hidenori Ando, Yu Ishima, i Tatsuhiro Ishida. "Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil(®)) in C26 Tumor-Bearing Immunocompetent Mice." Pharmaceutics 2020.

Cita MLA

Takayama, Takuma, et al. "Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil(®)) in C26 Tumor-Bearing Immunocompetent Mice." Pharmaceutics 2020.